Daewon Pharmaceutical Co. Ltd. - Asset Resilience Ratio

Latest as of March 2026: 4.71%

Daewon Pharmaceutical Co. Ltd. (003220) has an Asset Resilience Ratio of 4.71% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Explore 003220 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Liquid Assets

₩28.06 Billion

≈ $19.02 Million USD Cash + Short-term Investments

Total Assets

₩595.99 Billion

≈ $403.89 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how Daewon Pharmaceutical Co. Ltd.'s Asset Resilience Ratio has changed over time. See Daewon Pharmaceutical Co. Ltd. defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets Composition Over Time

This chart breaks down Daewon Pharmaceutical Co. Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 003220 current and non-current assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩28.06 Billion	4.71%
Total Liquid Assets	₩28.06 Billion	4.71%

Asset Resilience Insights

Limited Liquidity: Daewon Pharmaceutical Co. Ltd. maintains only 4.71% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Daewon Pharmaceutical Co. Ltd. Industry Peers by Asset Resilience Ratio

Compare Daewon Pharmaceutical Co. Ltd.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Cipla Limited NSE:CIPLA	Drug Manufacturers - Specialty & Generic	20.75%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	48.48%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	Drug Manufacturers - Specialty & Generic	1.18%
Shenzhen Chipscreen Biosciences Co SHG:688321	Drug Manufacturers - Specialty & Generic	5.10%
Bide Pharmatech Co. Ltd. A SHG:688073	Drug Manufacturers - Specialty & Generic	9.46%

Annual Asset Resilience Ratio for Daewon Pharmaceutical Co. Ltd. (2011–2025)

The table below shows the annual Asset Resilience Ratio data for Daewon Pharmaceutical Co. Ltd..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	4.77%	₩29.28 Billion ≈ $19.84 Million	₩613.65 Billion ≈ $415.86 Million	-0.21pp
2024-12-31	4.98%	₩29.05 Billion ≈ $19.69 Million	₩583.39 Billion ≈ $395.35 Million	+4.97pp
2023-12-31	0.01%	₩47.71 Million ≈ $32.33K	₩508.00 Billion ≈ $344.26 Million	-4.41pp
2022-12-31	4.42%	₩20.04 Billion ≈ $13.58 Million	₩453.55 Billion ≈ $307.36 Million	+1.36pp
2021-12-31	3.05%	₩13.12 Billion ≈ $8.89 Million	₩429.58 Billion ≈ $291.12 Million	+3.03pp
2020-12-31	0.02%	₩81.50 Million ≈ $55.23K	₩335.21 Billion ≈ $227.17 Million	-1.88pp
2019-12-31	1.91%	₩6.25 Billion ≈ $4.23 Million	₩327.53 Billion ≈ $221.96 Million	+1.22pp
2018-12-31	0.69%	₩1.89 Billion ≈ $1.28 Million	₩275.44 Billion ≈ $186.66 Million	-1.72pp
2017-12-31	2.41%	₩5.47 Billion ≈ $3.71 Million	₩227.20 Billion ≈ $153.97 Million	+0.02pp
2016-12-31	2.39%	₩5.13 Billion ≈ $3.48 Million	₩214.68 Billion ≈ $145.49 Million	-0.39pp
2015-12-31	2.78%	₩5.41 Billion ≈ $3.67 Million	₩194.75 Billion ≈ $131.98 Million	-0.87pp
2014-12-31	3.65%	₩6.59 Billion ≈ $4.47 Million	₩180.62 Billion ≈ $122.40 Million	-1.27pp
2013-12-31	4.92%	₩7.87 Billion ≈ $5.34 Million	₩160.14 Billion ≈ $108.52 Million	+4.58pp
2012-12-31	0.34%	₩499.06 Million ≈ $338.20K	₩147.13 Billion ≈ $99.70 Million	-0.09pp
2011-12-31	0.43%	₩597.00 Million ≈ $404.58K	₩140.39 Billion ≈ $95.14 Million	--

pp = percentage points

About Daewon Pharmaceutical Co. Ltd.

KO:003220 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$115.62 Million

₩170.61 Billion KRW

Market Cap Rank

#18773 Global

#882 in Korea

Share Price

₩7960.00

Change (1 day)

-0.25%

52-Week Range

₩7240.00 - ₩13450.00

All Time High

₩23535.34